VISX EXCIMER LASER SYSTEM MODEL C STAR

Excimer Laser System

FDA Premarket Approval P990010

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the visx excimer laser system model c (star s2) which included the right to reference information contained in p930016 from visx, inc. , of santa clara, ca. This device is indicated to perfrom lasik: 1) in patients 18 years of age or older in treatments for the reduction or elimination of myopia (nearsightedness) from 0 to -14. 0 diopters (d) with or without -0. 5 d to -5. 0 d of astigmatism; and 2) in patients with documented evidence of a change in manifest refraction of less than or equalto 0. 5 d (in both cylinder and sphere components) per year for at least one year prior to the date of pre-operative examination.

DeviceVISX EXCIMER LASER SYSTEM MODEL C STAR
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantAMO Manufacturing USA, LLC
Date Received1999-02-23
Decision Date1999-11-19
Notice Date2000-08-18
PMAP990010
SupplementS
Product CodeLZS
Docket Number00M-1447
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address AMO Manufacturing USA, LLC 510 Cottonwood Drive milpitas, CA 95035
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990010Original Filing
S008 2018-12-31 Real-time Process
S007 2014-07-07 Real-time Process
S006 2014-05-19 30-day Notice
S005
S004 2014-05-01 30-day Notice
S003
S002
S001 2000-04-12 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.